Radiation Therapy Oncology Group

This study compares two types of radiation therapy (proton and photon) combined with chemotherapy for people with stage II-IIIB non-small cell lung cancer that cannot be surgically removed. The goal is to see which approach helps patients live longer and causes fewer side effects…

This study looks at whether adding chemotherapy (cisplatin) to standard radiation therapy after surgery helps people with high-risk salivary gland tumors live longer without the cancer returning. About 252 adults whose tumors were removed took part. The goal is to see if the comb…

This phase 3 trial tests whether adding radiation to the whole pelvis, along with standard hormone therapy and prostate radiation, helps men with intermediate- or high-risk prostate cancer live longer. About 2,590 men are taking part. The study compares standard treatment (hormon…

This study tests whether a shorter, higher-dose radiation schedule (hypofractionation with a concurrent boost) works as well as the standard longer schedule for women with early-stage breast cancer after lumpectomy. Over 2,300 women participated. The goal is to see if the shorter…

This phase III trial studies whether adding the drug cetuximab to modern radiation therapy improves survival for people with advanced head and neck cancer that has been surgically removed. About 700 participants received either radiation alone or radiation plus cetuximab. The stu…